0001185185-18-000392.txt : 20180308 0001185185-18-000392.hdr.sgml : 20180308 20180308174333 ACCESSION NUMBER: 0001185185-18-000392 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171124 FILED AS OF DATE: 20180308 DATE AS OF CHANGE: 20180308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rafferty Joseph CENTRAL INDEX KEY: 0001733727 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55473 FILM NUMBER: 18677619 MAIL ADDRESS: STREET 1: 505 BEAUMONT CIRCLE CITY: WEST CHESTER STATE: PA ZIP: 19380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12424 WILSHIRE BLVD. STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: (310) 820-8100 MAIL ADDRESS: STREET 1: 12424 WILSHIRE BLVD. STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 4 1 form4-rafferty030818.xml OWNERSHIP DOCUMENT X0306 4 2017-11-24 0 0001530766 BioSig Technologies, Inc. BSGM 0001733727 Rafferty Joseph C/O BIOSIG TECHNOLOGIES, INC. 12424 WILSHIRE BLVD., SUITE 745 LOS ANGELES CA 90025 0 1 0 0 Chief Commercialization Offcr Common Stock 2018-03-05 4 P 0 7000 1.40 A 7000 D Stock Option (Right to Buy) 1.45 2017-11-24 4 A 0 420000 0.00 A 2027-11-24 Common Stock 420000 420000 D 120,000 of the optioned shares vested on November 24, 2017. The remaining optioned shares shall vest as follows: (i) 50,000 on November 24, 2019; (ii) 100,000 shares on the date that the first entity to have a PURE EP System installed converts to a paying customer of the company; (iii) 50,000 on the date that the company first files financial statements with the U.S. Securities and Exchange Commission on Form 10-K or Form 10-Q that report revenues, calculated in accordance with generally accepted accounting principles; and (iv) 100,000 on the date that the company first files financial statements with the U.S. Securities and Exchange Commission on Form 10-K that report annual revenues of at least $10,000,000, calculated in accordance with generally accepted accounting principles. /s/ Kenneth L. Londoner 2018-03-08